A detailed history of Hanson & Doremus Investment Management transactions in Novartis Ag stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 625 shares of NVS stock, worth $62,481. This represents 0.01% of its overall portfolio holdings.

Number of Shares
625
Previous 625 -0.0%
Holding current value
$62,481
Previous $71,000 15.49%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$106.13 - $120.89 $12,204 - $13,902
-115 Reduced 15.54%
625 $71,000
Q1 2023

Apr 18, 2023

SELL
$80.03 - $92.81 $312,357 - $362,237
-3,903 Reduced 84.06%
740 $68,000
Q4 2022

Jan 18, 2023

BUY
$75.55 - $92.52 $290,263 - $355,461
3,842 Added 479.65%
4,643 $421,000
Q3 2022

Oct 20, 2022

SELL
$74.61 - $87.26 $10,221 - $11,954
-137 Reduced 14.61%
801 $61,000
Q2 2022

Jul 19, 2022

SELL
$80.52 - $93.75 $2,737 - $3,187
-34 Reduced 3.5%
938 $79,000
Q1 2022

Apr 22, 2022

BUY
$80.11 - $90.62 $9,212 - $10,421
115 Added 13.42%
972 $85,000
Q3 2021

Oct 21, 2021

SELL
$81.78 - $95.14 $17,909 - $20,835
-219 Reduced 20.35%
857 $70,000
Q2 2021

Jul 22, 2021

SELL
$85.24 - $94.15 $317,689 - $350,897
-3,727 Reduced 77.6%
1,076 $94,000
Q1 2021

May 03, 2021

BUY
$83.5 - $98.47 $3,590 - $4,234
43 Added 0.9%
4,803 $411,000
Q4 2020

Feb 01, 2021

BUY
$78.07 - $94.43 $287,609 - $347,880
3,684 Added 342.38%
4,760 $449,000
Q2 2020

Jul 17, 2020

SELL
$80.93 - $91.1 $297,094 - $334,428
-3,671 Reduced 77.33%
1,076 $94,000
Q1 2020

Apr 24, 2020

BUY
$70.67 - $99.01 $270,171 - $378,515
3,823 Added 413.74%
4,747 $391,000
Q1 2019

Apr 23, 2019

BUY
$75.32 - $86.15 $16,495 - $18,866
219 Added 31.06%
924 $0
Q2 2018

Aug 08, 2018

SELL
$64.91 - $73.36 $266,325 - $300,996
-4,103 Reduced 85.34%
705 $53,000
Q1 2018

May 10, 2018

BUY
$70.39 - $84.15 $288,810 - $345,267
4,103 Added 581.99%
4,808 $389,000
Q3 2017

Oct 26, 2017

BUY
$74.14 - $77.27 $52,268 - $54,475
705
705 $0

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hanson & Doremus Investment Management Portfolio

Follow Hanson & Doremus Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.